(Reuters) - Medical equipment maker Steris beat third-quarter profit estimates, helped by strength in its core healthcare business driven by demand for .
Third quarter revenue increases 15% as reported; 10% constant currency organicAs reported diluted earnings per share increased to $1.42; adjusted earnings per share increased to $2.22Fiscal 2024.
Operator: Good morning, everyone and welcome to the STERIS plc Fiscal Second Quarter 2024 Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
Second quarter revenue growth of 12% as reported and 8% constant currency organicAs reported diluted earnings per share increased to $1.16; adjusted earnings increased to $2.03Fiscal 2024 outlook.